Cell therapy for cardiac regeneration after myocardial infarct: Which cell is the best?

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 8, Issue 4, 2010, Pages 227-243

  Mosna, Federico ^a   Annunziato, Francesco ^b   Pizzolo, Giovanni ^a   Krampera, Mauro ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acute myocardial infarction; Adult stem cells; Bone marrow; Cardiac regeneration; Cardiac stem cells; Cell therapy; Induced pluripotent stem cells; Mesenchymal stem cells

Indexed keywords

ATAXIN 1; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; PARATHYROID HORMONE; PROTEIN; PROTEIN ISL1; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW CELL; CARDIAC REGENERATION; CARDIAC STEM CELL; CARDIOSPHERE FORMING CELL; CD34 SELECTION; CELL; CELL DIFFERENTIATION; CELL FUSION; CELL ISOLATION; CELL LINEAGE; CELL SELECTION; CELL STRUCTURE; CELL THERAPY; CELL TYPE; CLINICAL ASSESSMENT; ECHOCARDIOGRAPHY; EMBRYO DEVELOPMENT; ENGRAFTMENT; GRAFT REJECTION; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INJECTION; MESENCHYMAL STEM CELL; MICROENVIRONMENT; MONONUCLEAR CELL; MYOBLAST; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REGENERATION; RISK BENEFIT ANALYSIS; STEM CELL; TERATOMA;

ANIMALS; CELL TRANSPLANTATION; CLINICAL TRIALS AS TOPIC; HEART; HUMANS; MICE; MYOCARDIAL INFARCTION; RATS; REGENERATION;

EID: 77958455452     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152510792481216     Document Type: Article

References (110)

1. Tomita, S.; Li, R.K.; Weisel, R.D.; Mickle, D.A.; Kim, E.J.; Sakai, T.; Jia, Z.Q. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation, 1999, 100, II247-II256.
2. Quaini, F.; Urbanek, K.; Beltrami, A.P.; Finato, N.; Beltrami, C.A.; Nadal-Ginard, B.; Kajstura, J.; Leri, A.; Anversa, P. Chimerism of the transplanted heart. N. Eng. J. Med., 2002, 346, 5-15.
3. Thiele, J.; Varus, E.; Wickenhauser, C.; Kvasnicka, H.M.; Lorenzen, J.; Gramley, F.; Metz, K.A.; Rivero, F.; Beelen, D.W. Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allografts. Transplantation, 2004, 77, 1902-1905.
4. Orlic, D.; Kajstura, J.; Chimenti, S.; Jakoniuk, I.; Anderson, S.M.; Baosheng, L.; Pickel, J.; McKay, R.; Nadal-Ginard, B.; Bodine, D.M.; Leri, A.; Anversa, P. Bone marrow cells regenerate infarctedmyocardium. Nature, 2001, 410, 701-705.
5. Orlic, D.; Kajstura, J.; Chimenti, S.; Limana, F.; Jakoniuk, I.; Quaini, F.; Nadal-Ginard, B.; Bodine, D.M.; Leri, A.; Anversa, P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA, 2001, 98, 10344-10349.
6. Jackson, K.A.; Majka, S.M.; Wang, H.; Pocius, J.; Hartley, C.J.; Majesky, M.W.; Entman, M.L.; Michael, L.H.; Hirschi, K.K.; Goodell, M.A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest., 2001, 107,1395-1402.
7. Deb, A.; Wang, S.; Skelding, K.A.; Miller, D.; Simper, D.; Caplice, N.M. Bone marrow-derived cardiomyoctes are present in adult human heart. A study of Gender-Mismatched Bone Marrow Transplantation Patients. Circulation, 2003, 107, 1247-1249.
8. Lee, M.S.; Makkar, R.R. Stem-Cell Transplantation in Myocardial Infarction: A Status Report. Ann. Intern. Med. 2004, 140, 729-737.
9. Lipinski, M.J.; Biondi-Zoccai, G.G.; Abbate, A.; Khianey, R.; Sheiban, I.; Bartunek, J., Vanderheyden, M.; Kim, H.S.; Kang, H.J.; Strauer, B.E.; Vetrovec, G.W. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J. Am. Coll. Cardiol., 2007, 50, 1761-1767.
10. Abdel-Latif, A.; Bolli, R.; Tleyjeh, I.M.; Montori, V.M.; Perin, E.C.; Hornung, C.A.; Zuba-Surma, E.K.; Al-Mallah, M.; Dawn, B. Adult bone marrow-derived cells for cardiac repair. A systematic review and meta-analysis. Arch. Intern. Med., 2007, 167, 989-997.
11. Dohmann, H.F.R.; Perin, E.C.; Takiya, C.M.; Silva, G.V.; Silva, S.A.; Sousa, A.L.S.; Mesquita, C.T.; Rossi, M.D.; Pascarelli, B.M.O.; Assis, I.M.; Dutra, H.S.; Assad, J.A.R.; Castello-Branco, R.V.; Drummond, C.; Dohmann, H.J.F.; Willerson, J.T.; Borojevic, R. Transendocardial autologous Bone Marrow Mononuclear Cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation, 2005, 112, 521-526.
12. Murry, C.E.; Soonpaa, M.H.; Reinecke, H.; Nakajima, H.; Nakajima, H.O.; Rubart, M.; Pasumarthi, K.B.; Viraq, J.I.; Bartelmez, S.H.; Poppa, V.; Bradford, G.; Dowell, J.D.; Williams, D.A.; Field, L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 2004, 428, 664-668.
13. Balsam, L.B.; Wagers, A.J.; Christensen, J.L.; Kofidis, T.; Weissman, I.L.; Robbins, R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature, 2004, 428, 668-673.
14. Yoon, Y.; Wecker, A.; Heyd, L.; Park, J.S.; Tkebuchava, T.; Kusano, K.; Hanley, A.; Scadova, H.; Qin, G.; Cha, D.H.; Johnson, K.L.; Aikawa, R.; Asahara, T.; Losordo, D.W. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest., 2005, 115, 326-338.
15. Meyer, G.P.; Wollert, K.C.; Lotz, J.; Steffens, J.; Lippolt, P.; Fichtner, S.; Hecker, H.; Schaefer, A.; Arseniev, L.; Hertenstein, B.; Ganser, A.; Drexler, H. Intrascoronary Bone Marrow Cell Transfer after Myocardial Infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial. Circulation, 2006, 113, 1287-1294.
16. Lunde, K.; Solheim, S.; Aakhus, S.; Arnesen, H.; Abdelnoor, M.; Egeland, T.; Endresen, K.; Ilebekk, A.; Mangschau, A.; Fjeld, J.G.; Smith, H.J.; Taraldsrud, E.; Grogaard, H.K.; Biorneheim, R.; Brekke, M.; Mueller, C.; Hopp, E.; Ragnarsson, A.; Brinchmann, J.E.; Forfang, K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med., 2006, 355, 1199-1209.
17. Schachinger, V.; Erbs, S.; Elsaesser, A.; Haberbosch, W.; Hambrecht, R.; Hoelschermann, H.; Yu, J.; Corti, R.; Mathey, D.G.; Hamm, C.W.; Sueselbeck, T.; Assmus, B.; Tonn, T.; Dimmeler, S.; Zeiher, A.M. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med., 2006, 355, 1210-1221.
18. Assmus, B.; Honold, J.; Schachinger, V.; Britten, M.B.; Fischer-Rasokat, U.; Lehmann, R.; Teupe, C.; Pistorius, K.; Martin, H.; Abolmaali, N.D.; Tonn, T.; Dimmeler, S.; Zeiher, A.M. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med., 2006, 355, 1222-1232.
19. Kawamoto, A.; Iwasaki, H.; Kusano, K.; Murayama, T.; Oyamada, A.; Silver, M.; Hulbert, C.; Gavin, M.; Hanley, A.; Ma, H.; Kearney, M.; Zak, V.; Asahara, T.; Losordo, D.W. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation, 2006, 114, 2163-2169.
20. Kocher, A.A.; Schuster, M.D.; Szabolcs, M.J.; Takuma, S.; Burkhoff, D.; Wang, J.; Homma, S.; Edwards, N.M.; Itescu, S. Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocytes apoptosis, reduces remodeling and improves cardiac function. Nat. Med., 2001, 7, 430-436.
21. + stem cells for intractable angina. A phase I/IIa double-blind, randomized controlled trial. Circulation, 2007, 115, 3165-3172.
22. Bartunek, J.; Vanderheyden, M.; Vandekerkhove, B.; Mansour, S.; De Bruyne, B.; De Bondt, P.; Van Heute, I.; Lootens, N.; Heyndrickx, G.; Wijns, W. Intracoronary Injection of CD133-positive Enriched Bone Marrow Progenitor Cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation, 2005, 112, I-178-I-183.
23. Pittenger, M.F.; Martin, B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res., 2004, 95, 9-20.
24. Makino, S.; Fukuda, K.; Miyoshi, S.; Konishi, F.; Kodama, H.; Pan, J.; Sano, M.; Takahashi, T.; Hori, S.; Abe, H.; Hata, J.; Umezawa, A.; Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest., 1999, 103, 697-705.
25. Hakuno, D.; Fukuda, K.; Makino, S.; Konishi, F.; Tomita, Y.; Manabe, T.; Suzuki, Y.; Umezawa, A.; Ogawa, S. Bone Marrowderived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors. Circulation, 2002, 105, 380-386.
26. Gallo, M.P.; Ramella, R.; Alloatti, G.; Penna, C.; Pagliaro, P.; Marcantoni, A.; Bonafé, F.; Losano, G.; Levi, R. Limited Plasticity of Mesenchymal Stem Cells Cocultured With Adult Cardiomyocytes. J. Cell Biochem., 2007, 100, 86-99.
27. Balana, B.; Nicoletti, C.; Zahanich, I.; Graf, E.M.; Christ, T.; Boxberger, S.; Ravens, U. 5-azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res., 2006, 16, 949-960.
28. Yoon, J.; Min, B.G.; Kim, Y.H.; Shim, W.J.; Ro, Y.M.; Lim, D.S. Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model. Acta Cardiol., 2005, 60, 277-284.
29. Shim, W.S.; Jiang, S.; Wong, P.; Tan, J.; Chua, Y.L.; Tan, Y.S.; Sin, Y.K.; Lim, C.H.; Chua, T.; Teh, M.; Liu, T.C.; Sim, E. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem. Biophys. Res. Commun., 2004, 324, 481-488.
30. Wang, T.; Xu, Z.; Jiang, W.; Ma, A. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocytes and smooth muscle cell. Int. J. Cardiol., 2006, 109, 74-81.
31. Planat-Bénard, V.; Menard, C.; André, M.; Puceat, M.; Perez, A.; Garcia-Verdugo, J.M.; Penicaud, L.; Casteilla, L. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ. Res., 2004, 94, 223-229.
32. Toma, C.; Pittenger, M.F.; Cahill, K.S.; Byrne, B.J.; Kessler, P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 2002, 105, 93-98.
33. Nagaya, N.; Fujii, T.; Iwase, T.; Ohgushi, H.; Itoh, T.; Uematsu, M.; Yamagishi, M.; Mori, H.; Kangawa, K.; Kitamura, S. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am. J. Physiol. Heart Circ. Physiol., 2004, 287, H2670-H2676.
34. Kawada, H.; Fujita, J.; Kinjo, K.; Matsuzaki, Y.; Tsuma, M.; Miyatake, H.; Muguruma, Y.; Tsuboi, K.; Itabashi, Y.; Ikeda, Y.; Ogawa, S.; Okano, H.; Hotta, T.; Ando, K.; Fukuda, K. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood, 2004, 104, 3581-3587.
35. Ripa, R.S.; Haack-Sorensen, M.; Wang, Y.; Jorgensen, E.; Mortensen, S.; Bindslev, L.; Friis, T.; Kastrup, J. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation, 2007, 116(1 Suppl), I24-I30.
36. Shake, J.G.; Gruber, P.J.; Baumgartner, W.A.; Senechal, G.; Meyers, J.; Redmond, J.M.; Pittenger, M.F.; Martin, B.J. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg., 2002, 73, 1919-1926.
37. Breitbach, M.; Bostani, T.; Roell, W.; Xia, Y.; Dewald, O.; Nygren, J.M.; Fries, J.W.; Tiemann, K.; Bohlen, H.; Hescheler, J.; Welz, A.; Bloch, W.; Jacobsen, S.E.; Fleischmann, B.K. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood, 2007, 110, 1362-1369.
38. Hattan, N.; Kawaguchi, H.; Ando, K.; Kuwabara, E.; Fujita, J.; Murata, M.; Suematsu, M.; Mori, H.; Fukuda, K. Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc. Res., 2005, 65, 334-344.
39. Tomita, Y.; Makino, S.; Hakuno, D.; Hattan, N.; Kimura, K.; Miyoshi, S.; Murata, M.; Ieda, M.; Fukuda, K. Application of mesenchymal stem cell-derived cardiomyocytes as bio-pacemakers: current status and problems to be solved. Med. Biol. Eng. Comput., 2007, 45, 209-220.
40. Chen, S.L.; Fang, W.W.; Qian, J.; Ye, F.; Liu, Y.H.; Shan, S.J.; Zhang, J.J.; Lin, S.; Liao, L.M.; Zhao, R.C. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med. J. (Engl.)., 2004, 117, 1443-1448.
41. Mohyeddin-Bonab, M.; Mohamad-Hassani, M.R.; Alimoghaddam, K.; Sanatkar, M.; Gaseemi, M.; Mirkhani, H.; Radmehr, H.; Salehi, M.; Eslami, M.; Farhing-Parsa, A.; Emami-Razavi, H.; al-Mohamad, M.G.; Solimani, A.A.; Ghavamzadeh, A.; Nikbin, B. Autologous in vitro expanded mesenchymal tem cell therapy for human old myocardial infarction. Arch. Iran Med., 2007, 10, 467-473.
42. Jiang, Y.; Jahagirdar, B.N.; Reinhardt, R.L.; Schwartz, R.E.; Keene, C.D.; Ortiz-Gonzalez, X.R.; Reyes, M.; Lenvik, T.; Lund, T.; Blackstad, M.; Du, J.; Aldrich, S.; Lisberg, A.; Low, W.C.; Largaespada, D.A.; Verfaillie, C.M. Pluripotency of mesenchymal stem cells derived form adult marrow. Nature, 2002, 418, 41-49.
43. Pelacho, B.; Nakamura, Y.; Zhang, J.; Ross, J.; Heremans, Y.; Nelson-Holte, M.; Lemke, B.; Hagenbrock, J.; Jiang, Y.; Prosper, F.; Luttun, A.; Verfaillie, C.M. Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction. J. Tissue Eng. Regen. Med., 2007, 1, 51-59.
44. Van't Hof, W.; Mal, N.; Huang, Y.; Zhang, M.; Popovic, Z.; Forudi, F.; Deans, R.; Penn, M.S. Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. Cytotherapy, 2007, 9, 477-487.
45. Agbulut, O.; Mazo, M.; Bressolle, C.; Gutierrez, M.; Azarnoush, K.; Sabbah, L.; Niederlander, N.; Abizanda, G.; Andreu, E.J.; Pelacho, B.; Gavira, J.J.; Perez-Ilzarbe, M.; Peyrard, S.; Bruneval, P.; Samuel, J.L.; Sortiano-Navarro, M.; Garcia-Verdugo, J.M.; Hagege, A.A.; Prosper, F.; Menasche, P. Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium? Cardiovasc. Res., 2006, 72, 175-183.
46. Aranguren, X.L.; Luttun, A.; Clavel, C.; Moreno, C.; Abizanda, G.; Barajas, M.A.; Pelacho, B.; Uriz, M.; Arana, M.; Echavarri, A.; Soriano, M.; Andreu, E.J.; Merino, J.; Garcia-Verdugo, J.M.; Verfaillie, C.M.; Prosper, F. In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells. Blood, 2007, 109, 2634-2642.
47. Beltrami, A.P.; Cesselli, D.; Bergamin, N.; Marcon, P.; Rigo, S.; Puppato, E.; D'Aurizio, F.; Verardo, R.; Piazza, S.; Pignatelli, A.; Poz, A.; Baccarani, U.; Damiani, D.; Fanin, R.; Mariuzzi, L.; Finato, N.; Masolini, P.; Burelli, S.; Belluzzi, O.; Schneider, C.; Beltrami, C.A. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood, 2007, 110, 3438-3446.
48. Dowell, J.; Rubart, M.; Pasumarthi, K.B.; Soonpaa, M.H.; Field, L.J. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc. Res., 2003, 58, 336-350.
49. Murtuza, B.; Suzuki, K.; Bou-Gharios, G.; Beauchamp, J.R.; Smolenski, R.T.; Partrifge, T.A.; Yacoub, M.H. Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc. Natl. Acad. Sci. USA, 2004, 101, 4216-4221.
50. Hagege, A.A.; Marolleau, J.P.; Vilquin, J.T.; Alheritiere, A.; Peyrard, S.; Duboc, D.; Abergel, E.; Messas, E.; Mousseaux, E.; Schwartz, K.; Desnos, M.; Menasche, P. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation, 2006, 114, I-108-I-113.
51. Smits, P.C.; van Geuns, R.J.; Poldermans, D.; Bountiokos, M.; Onderwater, E.E.; Lee, C.H.; Maat, A.P.; Serruys, P.W. Catheterbased intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol., 2003, 42, 2063-2069.
52. Dib, N.; Michler, R.E.; Pagani, F.D.; Wright, S.; Kereiakes, D.J.; Lengerich, R.; Binkley, P.; Buchele, D.; Anand, I.; Swingen, C.; Di Carli, M.F.; Thomas, J.D.; Jaber, W.A.; Opie, S.R.; Campbell, A.; McCarthy, P.; Yeager, M.; Dilsizian, V.; Griffith, B.P.; Korn, R.; Kreuger, S.K.; Ghazoul, M.; Robb MacLellan, W.; Fonarow, G.; Eisen, H.J.; Dinsmore, J.; Diethrich, E. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy; four-year follow-up. Circulation, 2005, 112, 1748-1755.
53. Menasche, P.; Alfieri, O.; Janssens, S.; McKenna, W.; Reichenspurner, H.; Trinquart, L.; Vilquin, J.T.; Marolleau, J.P.; Seymour, B.; Larghero, J.; Lake, S.; Chatellier, G.; Solomon, S.; Desnos, M.; Hagege, A.A. The myoblast autologous grafting in ischemic cardiomyoplasty (MAGIC) trial. First randomized placebo-controlled study of myoblast transplantation. Circulation, 2008, 117, 1189-1200.
54. Beltrami, A.P.; Barlucchi, L.; Torella, D.; Baker, M.; Limana, F.; Chimenti, S.; Kasahara, H.; Rota, M.; Muzzo, E.; Urbanek, K.; Leri, A.; Kajstura, J.; Nadal-Ginard, B.; Anversa, P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 2003, 114, 763-776.
55. Bearzi, C.; Rota, M.; Hosoda, T.; Tillmanns, J.; Nascimbene, A.; De Angelis, A.; Yasuzawa-Amano, S.; Trofimova, I.; Siggins, R.W.; LeCapitaine, N.; Cascapera, S.; Beltrami, A.P.; D'Alessandro, D.A.; Zias, E.; Quaini, F.; Urbanek, K.; Michler, R.E.; Bolli, R.; Kajstura, J.; Leri, A.; Anversa, P. Human cardiac stem cells. Proc. Natl. Acad. Sci. USA, 2007, 104, 14068-14073.
56. Leri, A.; Kajstura, J.; Anversa, P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol. Rev., 2005, 85, 1373-1416.
57. Urbanek, K.; Cesselli, D.; Rota, M.; Nascimbene, A.; De Angelis, A.; Hosoda, T.; Bearzi, C.; Boni, A.; Bolli, R.; Kajstura, J.; Anversa, P.; Leri, A. Stem cell niches in the adult mouse heart. Proc. Natl. Acad. Sci. USA, 2006, 103, 9226-9231.
58. Urbanek, K.; Rota, M.; Cascapera, S.; Bearzi, C.; Nascimbene, A.; De Angelis, A.; Hosoda, T.; Chimenti, S.; Baker, M.; Limana, F.; Nurzynska, D.; Torella, D.; Rotatori, F.; Rastaldo, R.; Musso, E.; Quaini, F.; Leri, A.; Kajstura, J.; Anversa, P. Cardiac Stem Cells possess Growth Factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res., 2005, 97, 663-673.
59. Urbanek, K.; Torella, D.; Sheikh, F.; De Angelis, A.; Nurzynska, D.; Silvestri, F.; Beltrami, C.A.; Bussani, R.; Beltrami, A.P.; Quaini, F.; Bolli, R.; Leri, A.; Kajstura, J.; Anversa, P. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. USA, 2005, 102, 8692-8697.
60. Leri, A.; Barlucchi, L.; Limana, F.; Deptala, A.; Darzynkiewicz, Z.; Hintze, T.H.; Kajstura, J.; Nadal-Ginard, B.; Anversa, P. Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc. Natl. Acad. Sci. USA, 2001, 98, 8626-8631.
61. Gonzalez, A.; Rota, M.; Nurzynska, D.; Misao, Y.; Tillmanns, J.; Ojaimi, C.; Padin-Iruegas, M.E.; Muller, P.; Esposito, G.; Bearzi, C.; Vitale, S.; Dawn, B.; Sanganalmath, S.K.; Baker, M.; Hintze, T.H.; Bolli, R.; Urbanek, K.; Hosoda, T.; Anversa, P.; Kajstura, J.; Leri, A. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ. Res., 2008, 102, 597-606.
62. Kajstura, J.; Leri, A.; Finato, N.; Di Loreto, C.; Beltrami, C.A.; Anversa, P. Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl. Acad. Sci. USA, 1998, 95, 8801-8805.
63. Chimenti, C.; Kajstura, J.; Torella, D.; Urbanek, K.; Heleniak, H.; Colussi, C.; Di Meglio, F.; Nadal-Ginard, B.; Frustaci, A.; Leri, A.; Maseri, A.; Anversa, P. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ. Res., 2003, 93, 604-613.
64. Rota, M.; LeCapitaine, N.; Hosoda, T.; Boni, A.; De Angelis, A.; Padin-Iruegas, M.E.; Esposito, G.; Vitale, S.; Urbanek, K.; Casarsa, C.; Giorgio, M.; Luscher, T.F.; Pelicci, P.G.; Anversa, P.; Leri, A.; Kajstura, J. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by depletion of the p66shc gene. Circ. Res., 2006, 99, 42-52.
65. Urbanek, K.; Quaini, F.; Tasca, G.; Torella, D.; Castaldo, C.; Nadal-Ginard, B.; Leri, A.; Kajstura, J.; Quaini, E.; Anversa, P. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl. Acad. Sci. USA, 2003, 100, 10440-10445.
66. Tillmanns, J.; Rota, M.; Hosoda, T.; Misao, Y.; Esposito, G.; Gonzalez, A.; Vitale, S.; Parolin, C.; Yasuzawa-Amano, S.; Muraski, J.; De Angelis, A.; LeCapitaine, N.; Siggins, R.W.; Loredo, M.; Bearzi, C.; Bolli, R.; Urbanek, K.; Leri, A.; Kajstura, J.; Anversa, P. Formation of large coronary arteries by cardiac progenitor cells. Proc. Natl. Acad. Sci. USA, 2008, 105, 1668-1673.
67. Linke, A.; Muller, P.; Nurzynska, D.; Casarsa, C.; Torella, D.; Nascimbene, A.; Castaldo, C.; Cascapera, S.; Bohm, M.; Quaini, F.; Urbanek, K.; Leri, A.; Hintze, T.H.; Kajstura, J.; Anversa, P. Stem cells in the dog heart are self-renewing, clonogenic and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc. Natl. Acad. Sci. USA, 2005, 102, 8966-8971.
68. Messina, E.; De Angelis, L.; Frati, G.; Morrone, S.; Chimenti, S.; Fiordaliso, F.; Salio, M.; Battaglia, M.; Latronico, M.V.; Coletta, M.; Vivarelli, E.; Frati, L.; Cossu, G.; Giacomello, A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res., 2004, 95, 911-921.
69. Smith, R.R.; Barile, L.; Cho, H.C.; Leppo, M.L.; Hare, J.M.; Messina, E.; Giacomello, A.; Abraham, M.R.; Marban, E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation, 2007, 115, 896-908.
70. Cai, C.L.; Liang, X.; Shi, Y.; Chu, P.H.; Pfaff, S.L.; Chen, J.; Evans, S. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell, 2003, 5, 877-889.
71. Sun, Y.; Liang, X.; Najafi, N.; Cass, M.; Lin, L.; Cai, C.L.; Chen, J.; Evans, S.M. Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells. Dev. Biol., 2007, 304, 286-296.
72. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell, 2006, 127, 1-15.
73. Laugwitz, K.L.; Moretti, A.; Lam, J.; Gruber, P.; Chen, Y.; Woodard, S.; Lin, L.Z.; Cai, C.L.; Lu, M.M.; Reth, M.; Platoshyn, O.; Yuan, J.X.J.; Evans, S.; Chien, K.R. Postnatal Isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature, 2005, 433, 647-653.
74. Yoon, J.; Choi, S.C.; Park, C.Y.; Choi, J.H.; Kim, Y.I.; Shim, W.J.; Lim, D.S. Bone Marrow-derived Side Population cells are capable of functional cardiomyogenic differentiation. Mol. Cells, 2008, 25, 216-223.
75. Hierlihy, A.M.; Seale, P.; Lobe, C.G.; Rudnicki, M.A.; Megeney, L.A. The post-natal heart contains a myocardial stem cell population. FEBS Lett., 2002, 530, 239-243.
76. + cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ. Res., 2005, 97, 52-61.
77. Oyama, T.; Nagai, T.; Wada, H.; Naito, A.T.; Matsuura, K.; Iwanaga, K.; Takahashi, T.; Goto, M.; Mikami, Y.; Yasuda, N.; Akazawa, H.; Uezumi, A.; Takeda, S.; Komuro, I. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J. Cell Biol., 2007, 176, 329-341.
78. Oh, H.; Bradfute, S.B.; Gallardo, T.D.; Nakamura, T.; Gaussin, V.; Mishina, Y.; Pocius, J.; Micheal, L.H.; Behringer, R.R.; Garry, D.J.; Entman, M.L.; Schneider, M.D. Cardiac progenitor cells from adult myocardium: homing, differentiation and fusion after infarction. Proc. Natl. Acad. Sci. USA, 2003, 100, 12313-12318.
79. Matsuura, K.; Nagai, T.; Nishigaki, N.; Oyama, T.; Nishi, J.; Wada, H.; Sano, M.; Toko, H.; Akazawa, H.; Sato, T.; Nakaya, H.; Kasanuki, H.; Komuro, I. Adult Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem., 2004, 279, 11384-11391.
80. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Yomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131, 861-872.
81. Yu, J.; Vodyanik, M.A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J.L.; Tian, S.; Nie, J.; Jonsdottir, G.A.; Ruotti, V.; Stewart, R.; Slukvin, I.I.; Thomson, J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318, 1917-1920.
82. Wernig, M.; Zhao, J.P.; Pruszak, J.; Hedlund, E.; Fu, D.; Soldner, F.; Broccoli, V.; Constantine-Paton, M.; Isacson, O.; Jaenisch, R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA, 2008, 105, 5856-5861.
83. Narazaki, G.; Uosaki, H.; Teranishi, M.; Okita, K.; Kim, B.; Matsuoka, S.; Yamanaka, S.; Yamashita, J.K. Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells. Circulation, 2008, 118, 498-506.
84. Gai, H.; Leung, E.L.; Costantino, P.D.; Aguila, J.R.; Nguyen, D.M.; Fink, L.M.; Ward, D.C.; Ma, Y. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts. Cell Biol. Int., 2009, 33, 1184-1193.
85. Kucia, M.; Dawn, B.; Hunt, G.; Guo, Y.; Wysoczynski, M.; Majka, M.; Ratajczak, J.; Rezzoug, F.; Ildstad, S.T.; Bolli, R.; Ratajczak, M.Z. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ. Res., 2004, 95, 1191-1199.
86. + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest., 2006, 116, 1865-1877.
87. Rota, M.; Kajstura, J.; Hosoda, T.; Bearzi, C.; Vitale, S.; Esposito, G.; Iaffaldano, G.; Padin-Iruegas, M.E.; Gonzalez, A.; Rizzi, R.; Small, N.; Muraski, J.; Alvarez, R.; Chen, X.; Urbanek, K.; Bolli, R.; Houser, S.R.; Leri, A.; Sussman, M.A.; Anversa, P. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc. Natl. Acad. Sci. USA, 2007, 104, 17783-17788.
88. Kajstura, J.; Rota, M.; Whang, B.; Cascapera, S.; Hosoda, T.; Bearzi, C.; Nurzynska, D.; Kasahara, H.; Zias, E.; Bonafè, M.; Nadal-Ginard, B.; Torella, D.; Nascimbene, A.; Quaini, F.; Urbanek, K.; Leri, A.; Anversa, P. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ, Res., 2005, 96, 127-137.
89. Burchfield, J.S.; Iwasaki, M.; Koyanagi, M.; Urbich, C.; Rosenthal, N.; Zeiher, A.M.; Dimmeler, S. Interleukin-10 from transplanted Bone Marrow Mononuclear Cells contributes to cardiac protection after myocardial infarction. Circ. Res., 2008, 103, 203-211.
90. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzencihler, B.; Schatteman, G.; Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275, 964-967.
91. Kawamoto, A.; Tkebuchava, T.; Yamaguchi, J.; Nishimura, H.; Yoon, T.S.; Milliken, C.; Uchida, S.; Masuo, O.; Iwaguro, H.; Ma, H.; Hanley, A.; Silver, M.; Keamey, M.; Losordo, D.W.; Isner, J.M.; Asahara, T. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation, 2003, 107, 461-468.
92. Badorff, C.; Brandes, R.P.; Popp, R.; Rupp, S.; Urbich, C.; Aicher, A.; Fleming, I.; Busse, R.; Zeiher, A.M.; Dimmeler, S. Trans differentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation, 2003, 107, 1024-1032.
93. Koyanagi, M.; Bushoven, P.; Iwasaki, M.; Urbich, C.; Zeiher, A.M.; Dimmeler, S. Notch signaling contributes to the expression of cardiac markers in human circulating progenitor cells. Circ. Res., 2007, 101, 1139-1145.
94. Barbash, I.M.; Chouraqui, P.; Baron, J.; Feinberg, M.S.; Etzion, S.; Tessone, A.; Miller, L.; Guetta, E.; Zipori, D.; Kedes, L.H.; Kloner, R.A.; Leor, J. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration and body distribution. Circulation, 2003, 108, 863-868.
95. Segers, V.F.M.; Van Riet, I.; Andries, L.J.; Lemmens, K.; Demolder, M.J.; De Becker, A.J.M.L.; Kockx, M.M.; De Keulenaer, G.W. Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am. J. Physiol. Heart Circ. Physiol., 2006, 290, H1370-H1377.
96. Fukushima, S.; Varela-Carver, A.; Coppen, S.R.; Yamahara, K.; Felkin, L.E.; Lee, J.; Barton, P.J.; Terracciano, C.M.; Yacoub, M.H.; Suzuki, K. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation, 2007, 115, 2254-2261.
97. Freyman, T.; Polin, G.; Osman, H.; Crary, J.; Lu, M.; Cheng, L.; Palasis, M.; Wilensky, R.L. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur. Heart J., 2006, 27, 1114-1122.
98. Yousef, M.; Schannwell, C.M.; Kostering, M.; Zeus, T.; Brehm, M.; Strauer, B.E. The BALANCE Study: Clinical Benefit and Long-Term Outcome After Intracoronary Autologous Bone Marrow Cell Transplantation in Patients With Acute Myocardial Infarction. J. Am. Coll. Cardiol., 2009, 53(24), 2262-2269.
99. Du, Y.Y.; Zhou, S.H.; Zhou, T.; Su, H.; Pan, H.W.; Du, W.H.; Liu, B.; Liu, Q.M. Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction. Cytotherapy, 2008, 10, 469-478.
100. Ballard, V.L.T.; Edelberg, J.M. Stem cells and the regeneration of the aging cardiovascular system. Circ. Res., 2007, 100, 1116-1127.
101. Leri, A.; Malhotra, A.; Liew, C.C.; Kajstura, J.; Anversa, P. Telomerase activity in rat cardiac myocytes is age and gender dependent. J. Mol. Cell Cardiol., 2000, 32, 385-390.
102. Martin, I.; Grotewiel, M.S. Oxidative damage and age-related functional declines. Mech. Ageing Dev., 2006, 127, 411-423.
103. Frustaci, A.; Kajstura, J.; Chimenti, C.; Jakoniuk, I.; Leri, A.; Maseri, A.; Nadal-Ginard, B.; Anversa, P. Myocardial Cell Death in Human Diabetes. Circ. Res., 2000, 87, 1123-1132.
104. Anversa, P.; Rota, M.; Urbanek, K.; Hosoda, T.; Sonnenblick, E.H.; Leri, A.; Kajstura, J.; Bolli, R. Myocardial aging - a stem cell problem. Basic Res. Cardiol., 2005, 100, 482-493.
105. Torella, D.; Rota, M.; Nurzynska, D.; Musso, E.; Monsen, A.; Shiraishi, I.; Zias, E.; Walsh, K.; Rosenzweig, A.; Sussman, M.A.; Urbanek, K.; Nadal-Ginard, B.; Kajstura, J.; Anversa, P.; Leri, A. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ. Res., 2004, 94, 514-524.
106. Scheubel, R.J.; Zorn, H.; Silber, R.E.; Kuss, O.; Morawietz, H.; Holtz, J.; Simm, A. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J. Am. Coll. Cardiol., 2003, 42, 2073-2080.
107. Itzhaki-Alfia, A.; Leor, J.; Raanani, E.; Sternik, L.; Spiegelstein, D.; Netser, S.; Holbova, R.; Pevsner-Fischer, M.; Lavee, J.; Barbash, I.M. Patient characteristics and cell source determine the number of isolated Human Cardiac Progenitor Cells. Circulation, 2009, 120, 2559-2566.
108. Kubo, H.; Jaleel, N.; Kumarapeli, A.; Berretta, R.M.; Bratinov, G.; Shan, X.; Wang, H.; Houser, S.R.; Margulies, K.B. Increased cardiac myocyte progenitors in failing human hears. Circulation, 2008, 118, 649-657.
109. Forrester, J.S.; Price, M.J.; Makkar, R.R. Stem Cell Repair of Infarcted Myocardium; An Overview for Clinicians. Circulation, 2003, 108, 1139-1145.
110. Sensebé, L.; Krampera, M.; Schrezenmeier, H.; Bourin, P.; Giordano, R. Mesenchymal stem cells for clinical application. Vox Sang., 2010, 98, 93-107.